These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38745385)

  • 1. Molecular Insights into the Effects of F16L and F19L Substitutions on the Conformation and Aggregation Dynamics of Human Calcitonin.
    Huang F; Huang J; Yan J; Liu Y; Lian J; Sun Q; Ding F; Sun Y
    J Chem Inf Model; 2024 Jun; 64(11):4500-4510. PubMed ID: 38745385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Perturbation of Monomers Determines the Amyloid Aggregation Propensity of Calcitonin Variants.
    Liu Y; Wang Y; Zhang Y; Zou Y; Wei G; Ding F; Sun Y
    J Chem Inf Model; 2023 Jan; 63(1):308-320. PubMed ID: 36456917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the influence of Y12L and N17H substitutions on the conformation and oligomerization of human calcitonin.
    Yan J; Wang Y; Fan X; Zou Y; Ding F; Huang F; Sun Y
    Soft Matter; 2024 Jan; 20(3):693-703. PubMed ID: 38164981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of aromatic residues in amyloid fibril formation of human calcitonin by solid-state 13C NMR and molecular dynamics simulation.
    Itoh-Watanabe H; Kamihira-Ishijima M; Javkhlantugs N; Inoue R; Itoh Y; Endo H; Tuzi S; Saitô H; Ueda K; Naito A
    Phys Chem Chem Phys; 2013 Jun; 15(23):8890-901. PubMed ID: 23552643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlling the self-assembly of human calcitonin: a theoretical approach using molecular dynamics simulations.
    Paul S; Paul S
    Phys Chem Chem Phys; 2021 Jul; 23(26):14496-14510. PubMed ID: 34184696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time.
    Kamgar-Parsi K; Hong L; Naito A; Brooks CL; Ramamoorthy A
    J Biol Chem; 2017 Sep; 292(36):14963-14976. PubMed ID: 28739873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting Human Calcitonin Fibril Formation with Its Most Relevant Aggregation-Resistant Analog.
    Chen YT; Hu KW; Huang BJ; Lai CH; Tu LH
    J Phys Chem B; 2019 Dec; 123(48):10171-10180. PubMed ID: 31692350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular insights into the oligomerization dynamics and conformations of amyloidogenic and non-amyloidogenic amylin from discrete molecular dynamics simulations.
    Wang Y; Liu Y; Zhang Y; Wei G; Ding F; Sun Y
    Phys Chem Chem Phys; 2022 Sep; 24(36):21773-21785. PubMed ID: 36098068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design, conformational studies and bioactivity of highly potent conformationally constrained calcitonin analogues.
    Kapurniotu A; Kayed R; Taylor JW; Voelter W
    Eur J Biochem; 1999 Oct; 265(2):606-18. PubMed ID: 10504392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformationally constrained human calcitonin (hCt) analogues reveal a critical role of sequence 17-21 for the oligomerization state and bioactivity of hCt.
    Kazantzis A; Waldner M; Taylor JW; Kapurniotu A
    Eur J Biochem; 2002 Feb; 269(3):780-91. PubMed ID: 11846779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine 12 of human calcitonin modulates its amyloid formation, membrane binding, and bioactivity.
    Hsieh IC; Chen TW; Chuang YP; Lai YJ; Tu LH
    Biochimie; 2022 Jun; 197():121-129. PubMed ID: 35240220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converting the highly amyloidogenic human calcitonin into a powerful fibril inhibitor by three-dimensional structure homology with a non-amyloidogenic analogue.
    Andreotti G; Vitale RM; Avidan-Shpalter C; Amodeo P; Gazit E; Motta A
    J Biol Chem; 2011 Jan; 286(4):2707-18. PubMed ID: 21078667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling the underlying mechanisms of reduced amyloidogenic properties in human calcitonin via double mutations.
    Chang YP; Pan PC; Tu LH
    Protein Sci; 2024 Apr; 33(4):e4952. PubMed ID: 38501491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unveiling Medin Folding and Dimerization Dynamics and Conformations via Atomistic Discrete Molecular Dynamics Simulations.
    Huang F; Fan X; Wang Y; Wang C; Zou Y; Lian J; Ding F; Sun Y
    J Chem Inf Model; 2023 Oct; 63(20):6376-6385. PubMed ID: 37782573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructure and stability of calcitonin amyloids.
    Rigoldi F; Metrangolo P; Redaelli A; Gautieri A
    J Biol Chem; 2017 May; 292(18):7348-7357. PubMed ID: 28283568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleation of β-rich oligomers and β-barrels in the early aggregation of human islet amyloid polypeptide.
    Sun Y; Kakinen A; Xing Y; Pilkington EH; Davis TP; Ke PC; Ding F
    Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):434-444. PubMed ID: 30502402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG.
    Huang R; Vivekanandan S; Brender JR; Abe Y; Naito A; Ramamoorthy A
    J Mol Biol; 2012 Feb; 416(1):108-20. PubMed ID: 22200484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the inhibitory property of DM hCT on hCT fibrillization via its relevant peptide fragments.
    Chuang YP; Chang YP; Tu LH
    Protein Sci; 2023 Aug; 32(8):e4711. PubMed ID: 37354016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and conformational requirements for human calcitonin activity: design, synthesis, and study of lactam-bridged analogues.
    Kapurniotu A; Taylor JW
    J Med Chem; 1995 Mar; 38(5):836-47. PubMed ID: 7877149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme prevents highly amyloidogenic human calcitonin (hCT) aggregation: A potential new strategy for the clinical reuse of hCT.
    Ye H; Zhou J; Li H; Gao Z
    J Inorg Biochem; 2019 Jul; 196():110686. PubMed ID: 31003065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.